Article Details
Retrieved on: 2021-03-11 21:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A phase 3 trial evaluating tocilizumab (Actemra®) in combination with remdesivir (Veklury®) for the treatment of severe COVID-19 pneumonia did not ...
Article found on: www.empr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here